Buprenorphine Treatment for Opioid Use Disorder in HIV Primary Care (integrated buprenorphine treatment) is an evidence-informed intervention to safely reduce opioid use disorder and improve HIV health outcomes among people with HIV. In collaboration with HIV experts and community members, E2i adapted integrated buprenorphine treatment for the Ryan White HIV/AIDS Program (RWHAP) and produced a toolkit that provides the resources needed to implement integrated buprenorphine treatment within RWHAP settings and other HIV care organizations. Algunos recursos están disponibles en español.
Replication Resources
Part of Collection
Developed by
